Natural Products as Leads in Schistosome Drug Discovery
AbstractSchistosomiasis is a neglected parasitic tropical disease that claims around 200,000 human lives every year. Praziquantel (PZQ), the only drug recommended by the World Health Organization for the treatment and control of human schistosomiasis, is now facing the threat of drug resistance, indicating the urgent need for new effective compounds to treat this disease. Therefore, globally, there is renewed interest in natural products (NPs) as a starting point for drug discovery and development for schistosomiasis. Recent advances in genomics, proteomics, bioinformatics, and cheminformatics have brought about unprecedented opportunities for the rapid and more cost-effective discovery of new bioactive compounds against neglected tropical diseases. This review highlights the main contributions that NP drug discovery and development have made in the treatment of schistosomiasis and it discusses how integration with virtual screening (VS) strategies may contribute to accelerating the development of new schistosomidal leads, especially through the identification of unexplored, biologically active chemical scaffolds and structural optimization of NPs with previously established activity. View Full-Text
Share & Cite This Article
Neves, B.J.; Andrade, C.H.; Cravo, P.V.L. Natural Products as Leads in Schistosome Drug Discovery. Molecules 2015, 20, 1872-1903.
Neves BJ, Andrade CH, Cravo PVL. Natural Products as Leads in Schistosome Drug Discovery. Molecules. 2015; 20(2):1872-1903.Chicago/Turabian Style
Neves, Bruno J.; Andrade, Carolina H.; Cravo, Pedro V.L. 2015. "Natural Products as Leads in Schistosome Drug Discovery." Molecules 20, no. 2: 1872-1903.